Alnylam Pharmaceuticals
ALNY
#640
Rank
A$50.99 B
Marketcap
$389.15
Share price
-0.81%
Change (1 day)
69.31%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company